Position in NBIX
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$335,900
+$126,701 QoQ
Shares Held
1,993
+35.1% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#115
of 226 holders
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026GREENLEAF TRUST holds $3,898,206 across 6 Drug Manufacturers - Specialty & Generic names. NBIX ranks #5 (8.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RDY |
Dr Reddys Laboratories Ltd
|
121,466 | $1,760,042 | |
| 2 | VTRS |
Viatris Inc
|
36,589 | $581,033 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
1,057 | $572,714 | |
| 4 | ZTS |
Zoetis Inc.
|
4,763 | $342,269 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
This page
|
1,993 | $335,900 | |
| 6 | ALKS |
Alkermes plc.
|
5,845 | $306,248 |
All Filings in NBIX
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $335,900 | 1,993 | Shares | Defined | 2026-07-21 | |
| 2025-12-31 | $209,199 | 1,475 | Shares | Sole | 2026-01-21 | |
| No filing history on record for this holder in this stock. | ||||||